What monitoring is required for patients requiring parenteral narcotics or sedative agents?

• A. Intermittent vital signs every 15 minutes.
• B. Cardiac monitor only.
• C. Continuous cardiac, SpO2, and ETCO2 monitoring.
• D. No monitoring is required.

Answer: (C)

Continuous monitoring of respiratory status, oxygenation, and cardiac function is needed because parenteral narcotics or sedatives can rapidly depress breathing and affect heart rate and rhythm. Pulse oximetry shows how well oxygen is being carried in the blood, but it can miss early trouble because oxygen levels may stay normal for a while. End-tidal CO2 (capnography) tracks ventilation in real time, so you can detect hypoventilation or apnea as soon as it begins. Cardiac monitoring catches any drug-related changes in heart rate or rhythm. Putting these together gives a complete, real-time view of the patient’s status and allows swift intervention if problems arise. Intermittent vital signs or monitoring that excludes one of these modalities could miss critical deterioration, and no monitoring is unsafe.